Calvert Labs In Production with Pristima™
Cedar Knolls, NJ December 1, 2009
Xybion Medical Systems, the developer of Pristima™ the premier preclinical software solution on the market and a world leader in toxicology and pathology software solutions for medical and chemical research, is proud to announce that Calvert Labs has licensed, validated and placed Pristima™ into production.
Using Xybion's Standard Validation Package to accelerate its implementation and validation of Pristima, Calvert was able to leverage its internal resources to execute the validation along with Xybion's installation, training and configuration services. Calvert's project to implement Pristima is part of a larger effort to enhance its technical capabilities to further automate data collection, accelerate study reporting and to add the ability to post results to their clients utilizing near real-time technologies .
Using Xybion's Standard Validation Package to accelerate its implementation and validation of Pristima, Calvert was able to leverage its internal resources to execute the validation along with Xybion's installation, training and configuration services. Calvert's project to implement Pristima is part of a larger effort to enhance its technical capabilities to further automate data collection, accelerate study reporting and to add the ability to post results to their clients utilizing near real-time technologies .
Dr. Pradip Banerjee, Xybion's Chief Executive Officer, stated "We are proud to add Calvert Labs to the Xybion client community. This is a world-class contract research organization serving the pharmaceutical and biotechnology industries and we are pleased that they have moved quickly to license, validate and place the system into production." Dr. Banerjee added, "Their strategy to take on a wider variety of studies, offer more flexibility in their study designs and to make study reports available to clients quickly, fits right in with Xybion's strategy to provide the most comprehensive, flexible, and powerful system on the market. We are tremendously satisfied that Calvert has acknowledged Xybion as its ideal information systems partner and is integrating the Pristima preclinical solution into its full array of products and services. "
Allan Reiss, CEO of Calvert Labs, remarked that "Our business differentiator is to offer clients a customized, responsive and proven approach to preclinical services. Xybion's Pristima solution fit right in with our strategy." Jeffrey Pallman, Associate Director of Toxicology, also noted: "We take pride in our track record in this industry. None of our programs have ever encountered problems at any regulatory agency because of program design, performance, or data collection. We selected Xybion as a partner after careful consideration of this legacy in the market."
After extensive research to improve its ability to bring near-real time data to our customerss, Calvert selected Xybion's Pristima solution to manage its general toxicology data as well as licensing Xybion's Standard Validation Package. Additionally, Calvert contracted Xybion to provide a full suite of professional services in order to achieve a tailored solution to match Calvert's needs.
About Calvert Labs:
Calvert Laboratories provides contract services to pharmaceutical and biotechnology companies that will generate data and information necessary to file any regulatory submission with international government health service regulatory bodies. Calvert Labs services include acute, subchronic, chronic toxicology and carcinogenicity evaluations, safety pharmacology, discovery pharmacology, telemetry, pharmacokinetic studies, immunology and immunotoxicology. Calvert Labs
About Xybion Medical Systems:
Xybion is the enterprise system partner of choice for life sciences product companies and research organizations worldwide. In addition to Pristima, Xybion provides professional services, consulting, training and validation activities to clients throughout the world. Xybion Medical Systems